Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
That is two full syringes
BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, KPV is a tripeptide fragment of -MSH, PEA (palmitoylethanolamide) is a naturally occurring fatty acid amide, and Tributyrin is a prodrug of butyric acid
Medicaid rates vary by state from approximately $15 to $40, and private insurers typically pay between $30 and $50 per injection
Quality comes down to transparency
Removal from a compounding-restriction list is not an approval
BPC-157 is most often considered when: Recovery from a musculoskeletal injury has stalled beyond the expected timeline Inflammation appears to be a persistent driver rather than an acute protective response Gut lining integrity is a concern as part of a broader inflammatory or digestive picture The patient is a reasonable candidate for physician-supervised peptide therapy based on health history and risk profile It is not appropriate when there is an unresolved structural question that imaging should answer first, when there are acute red flag symptoms warranting urgent evaluation, or when the individual is hoping a peptide will substitute for rehabilitation and load management
US$ 27.29
US$ 23.82
US$ 21.79
US$ 21.52
&srotate=0)
US$ 20.97
US$ 27.59
US$ 25.65
